FOREST BANKING ON SYNCHRON TECHNOLOGY TO CAPITALIZE ON "SPECIAL OPPORTUNITY" IN GENERICS OFFERED BY HATCH/WAXMAN LAW, PRESIDENT SOLOMON TELLS ANALYSTS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".